Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$2.0MFederal grants as PI2 awards
6Patents grantedLatest Feb 25, 2025
94Papers1,887 citations
Federal awards and patents by year
AwardsPatents
2 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 6, 2022 | NIH | SBIR Phase II Selection of a lead LPAR1 antagonist for treatment of diabetic neuropathy | $991K | Epigen Biosciences, Inc. |
| May 20, 2021 | NIH | SBIR Phase II Selection of a lead LPAR1 antagonist for treatment of diabetic neuropathy | $1.0M | Epigen Biosciences, Inc. |
7 patents as inventor
- US 10000459Epigen Biosciences, Inc.Jun 19, 2018
- US 10526298Epigen Biosciences, Inc.Jan 7, 2020
- US 10570103Epigen Biosciences, Inc.Feb 25, 2020
- US 11427552Epigen Biosciences, Inc.Aug 30, 2022
- US 11866421Epigen Biosciences, Inc.Jan 9, 2024
- US 12234224Epigen Biosciences, Inc.Feb 25, 2025
- US Epigen Biosciences, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#984
Awards as PI#1,252
Patents#15
Companies
- Epigen Biosciences, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.